Medicare AdvantageCoverageMedium impact
MA07.050n, Electromyography (EMG) Studies, Nerve Conduction Studies (NCS), and Related Electrodiagnostic Studies
Independence Blue Cross·Neurology, PM&R (Physical Medicine & Rehab), Pain Management·Medical Policy
Effective date
Apr 1, 2026
We identified it
Jun 19, 2026
Summary
Policy MA07.050n regarding Electromyography (EMG) Studies, Nerve Conduction Studies (NCS), and Related Electrodiagnostic Studies has been reissued effective 04/01/2026. This is a recent policy update (1 month old) that supersedes previous guidance. The billing team must review the full policy content to identify specific coverage, billing code, prior authorization, or documentation changes applicable to EMG/NCS procedures.
Action Required
By March 15, 2026: Billing team must obtain and review the complete text of policy MA07.050n from the source URL (https://medpolicy.ibx.com/ibc/ma/Pages/Site-Activity-View.aspx?FilterField1=MPSiteActivityLogMonth&FilterValue1=04&FilterField2=MPSiteActivityLogYear&FilterValue2=2026#medicare-advantage-ma07-050n-electromyography-emg-studies-ne) to identify specific CPT/HCPCS codes affected, prior authorization requirements, documentation mandates, and coverage limitations. Update billing software, encounter templates, and provider guidelines accordingly. Notify providers performing EMG/NCS studies of any changes. Ensure all claims submitted on or after 04/01/2026 comply with reissued requirements. Failure to implement changes may result in claim denials.